More about

Sacituzumab Govitecan

News
September 19, 2020
4 min read
Save

Sacituzumab govitecan improves survival in pretreated triple-negative breast cancer

Sacituzumab govitecan improves survival in pretreated triple-negative breast cancer

Sacituzumab govitecan significantly improved PFS and OS compared with single-agent chemotherapy.

News
April 23, 2020
1 min read
Save

FDA approves Trodelvy for metastatic triple-negative breast cancer

FDA approves Trodelvy for metastatic triple-negative breast cancer

The FDA granted accelerated approval to sacituzumab govitecan-hziy for treatment of certain adults with metastatic triple-negative breast cancer.

News
April 09, 2020
1 min read
Save

FDA grants fast track designation to sacituzumab govitecan for urothelial cancer subset

FDA grants fast track designation to sacituzumab govitecan for urothelial cancer subset

The FDA granted fast track designation to sacituzumab govitecan for treatment of certain adults with locally advanced or metastatic urothelial cancer.

News
August 21, 2024
3 min watch
Save

VIDEO: Recent approvals in breast cancer

VIDEO: Recent approvals in breast cancer

Healio spoke with Roberto A. Leon-Ferre, MD, about recent approvals in breast cancer.

View more